
This annual symposium celebrates the partnership between Children’s National Hospital and the National Institute of Allergy and Infectious Diseases (NIAID). Established in 2017, the Children's National - NIAID partnership focuses on advancing the health of children with allergic, immunologic, and infectious diseases through collaborative research and education.
The event was held on Thursday, April 27 and Friday, April 28, 2023 at the Children’s National Research and Innovation Campus in DC. Together with our co-host, the Pediatric Pandemic Network (PPN), we will focus on Promoting Child Health: From Environmental Challenges to Pandemic.
The Pediatric Pandemic Network is a network of 10 children’s hospitals that serve as regional hubs for improving care for all children, their families, and communities in pandemics, disasters and every day. The PPN works with regional and national programs, academic institutions, community organizations, and individual experts to share pediatric-related information, educational resources, and best practices. In 2023, the priority focus areas for PPN activities include infectious disease/disease outbreaks, mental and behavioral health, healthcare emergency management, and health equity and community engagement.
Funding for this event has been provided by Children's National Research Institute, Center for Cancer and Immunology, and Center for Translational Research.
Day 1, Thursday, April 27, 2023 | VIEW VIDEO RECORDINGS >
Day 2, Friday, April 28, 2023 | VIEW VIDEO RECORDINGS >
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Society of Virginia (MSV) through the joint providership of Inova Office of Continuing Medical Education and Children's National Medical Center. The Inova Office Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing education for physicians.
Credit Designation:
The Inova Office of Continuing Medical Education designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 7.5 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.
Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME.
Catherine Bollard, MD, MBChB, planner for this educational event, has honorarium relationship with Mana Therapeutics, Catamaran Bio, Cabaletta Bio; receipt of intellectual property rights relationship with Mana Therapeutics and Catamaran Bio; ownership relationship with Mana Therapeutics, Catamaran Bio, Cabaletta Bio; consulting relationship with Sobi, Pfizer, BMS, Cellectar. All relevant financial relationships listed for this individual has been mitigated.
Maria Elena Bottazzi, PhD, faculty for this educational event, has royalty relationship with Biological E BioFarma. All relevant financial relationships listed for this individual has been mitigated.
Tamera Coyne Beasley, MD, MPH, faculty for this educational event, has consulting relationship with Pfizer, Moderna, Sanofi Pasteur. All relevant financial relationships listed for this individual has been mitigated.
Ruchi Gupta, MD, faculty for this educational event, has contracted research relationship with Novartis; consulting relationship with Genentech, Novartis, Aimmune LLC, Allergenis LLC; ownership relationship with Yobee Care, Inc. All relevant financial relationships listed for this individual has been mitigated.
Larry Kociolek, MD, faculty for this educational event, has contracted research relationship with Merck. All relevant financial relationships listed for this individual has been mitigated.